Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.8M | $6.4M | $6.6M | $9.3M | $9.9M | $6.5M | $267 | $111.6K |
| Cost of revenue | $5.5M | $4.1M | $4.3M | $2.2M | $2.7M | $2.9M | $1.7K | $111.4K |
| Gross profit | $2.3M | $2.3M | $2.3M | $7.0M | $7.3M | $3.6M | −$1.5K | $220 |
| Gross margin | 29.6% | 36.1% | 34.7% | 75.9% | 73.2% | 56.1% | -554.7% | 0.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$281.0K | −$168.0K | −$467.0K | $4.6M | $4.9M | $1.9M | −$1.6M | −$1.8M |
| EBITDA | $1.2M | $1.7M | $665.9K | $5.5M | $5.8M | $2.9M | −$817.0K | −$1.2M |
| Net income | $159.6K | $1.3M | −$317.0K | $3.3M | $3.6M | $1.3M | −$354.0K | −$409.0K |
| Net margin | 2.0% | 20.6% | -4.8% | 35.7% | 35.8% | 19.9% | -132584.3% | -366.6% |
| EPS (diluted) | 0.00 | 0.02 | -0.00 | 0.05 | 0.05 | 0.02 | -0.01 | -0.01 |
Annual figures · source: Financial Modeling Prep
CHINA HEALTH INDS HLDGS
No one on the platform currently holds CHHE.
No tracked institution reports a position in CHHE as of their last filing.
No one on the platform has traded CHHE yet.
| $7M |
| — |
| MYCOFNoveris Health Sciences Inc. | $2.00 | +0.00% | $117M | — |
| NUMIFNuminus Wellness Inc. | $0.02 | +3.00% | $7M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 692.5× historical median P/S.
Fair value ≈ $0.57 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.